{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477221827
| IUPAC_name = (''RS'')-1-(4-Fluorophenyl)-''N''-methylpropan-2-amine
| image = 4-FMA.svg
| image2 = 4-Fluoromethamphetamine molecule ball.png
| alt2 = Ball-and-stick model of the 4-fluoromethamphetamine molecule

<!--Clinical data-->
| tradename =  
| legal_CA = Schedule I
| legal_DE = Anlage II
| legal_UK = Class A
| legal_AU = S9
| routes_of_administration =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 351-03-1
| CAS_supplemental = <br /> 52063-62-4 (hydrochloride)
| PubChem = 11745017
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 9919721
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 8LLF59DO7F

<!--Chemical data-->
| C=10 | H=14 | F=1 | N=1 
| molecular_weight = 167.223 g/mol
| smiles = Fc1ccc(cc1)CC(NC)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H14FN/c1-8(12-2)7-9-3-5-10(11)6-4-9/h3-6,8,12H,7H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YCWZPIHKUYZTFM-UHFFFAOYSA-N
}}

'''4-Fluoromethamphetamine''' ('''4-FMA''') is a [[stimulant]] drug related to [[methamphetamine]] and [[4-Fluoroamphetamine|4-fluoroamphetamine]]. It has been reported to be sold as a [[designer drug]], but little is known about its pharmacology or toxicology.<ref name=Rösner >{{Cite journal | last1 = Rösner | first1 = P. | last2 = Quednow | first2 = B. | last3 = Girreser | first3 = U. | last4 = Junge | first4 = T. | title = Isomeric Fluoro-methoxy-phenylalkylamines: A new series of controlled-substance analogues (designer drugs) | doi = 10.1016/j.forsciint.2004.05.003 | journal = Forensic Science International | volume = 148 | issue = 2–3 | pages = 143–156 | year = 2005 | pmid =  15639609| pmc = }}</ref> It was first detected from [[legal highs]] sold in Japan in 2006 and became illegal to sell or to possess for the purpose of distribution (although not to simply possess for personal use) in Japan in 2008.<ref>{{Cite journal |author1=Machiko Nagashima |author2=Takako Seto |author3=Misako Takahashi |author4=Jin Suzuki |author5=Ichirou Yasuda | title = Spectrum Data of the 3rd Governor-designated Drugs and the Analyses of Uncontrolled Drugs Purchased | journal =  Annu. Rep. Tokyo Metr. Inst. Public Health | volume = 57 | pages = 109–113 | year = 2006 | url = http://www.tokyo-eiken.go.jp/issue/journal/2006/pdf/57-14.pdf}}</ref> It was initially reported to be contained as an ingredient in some of the range of [[party pills]] sold internationally by the Israeli company Neorganics from around 2006 onwards, but this was later shown to be incorrect and this ingredient was eventually identified as the closely related compound [[2-fluoromethamphetamine]].<ref>{{cite journal | last1 = Camilleri | first1 = A | last2 = Johnston | first2 = MR | last3 = Brennan | first3 = M | last4 = Davis | first4 = S | last5 = Caldicott | first5 = DG | title = Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone | journal = Forensic Science International | volume = 197 | issue = 1–3 | pages = 59–66 | year = 2010 | pmid = 20074881 | doi = 10.1016/j.forsciint.2009.12.048 }}</ref>

==Pharmacology==
4-FMA is a [[CYP450]] inhibitor. It reduces the metabolism of [[methamphetamine]], which has the effect of increasing its potency, duration and systemic toxicity while also reducing its cellular toxicity.<ref>{{Cite journal 
| last1 = Cherner | first1 = M. 
| last2 = Bousman | first2 = C. 
| last3 = Everall | first3 = I. A. N. 
| last4 = Barron | first4 = D. 
| last5 = Letendre | first5 = S. 
| last6 = Vaida | first6 = F. 
| last7 = Atkinson | first7 = J. H. 
| last8 = Heaton | first8 = R. 
| last9 = Grant | first9 = I. 
| last10 = Hnrc | first10 = G. 
| doi = 10.1017/S1355617710000779 
| title = Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findings 
| journal = Journal of the International Neuropsychological Society 
| volume = 16 
| issue = 5 
| pages = 890–901 
| year = 2010 
| pmid = 20727252 
| pmc =3543816 
}}</ref>
==Legal status==

===Australia===
4-FMA is considered a Schedule 9 substance in Australia under the [[Standard for the Uniform Scheduling of Medicines and Poisons|Poisons Standard]] (October 2015).<ref name="Poisons Standard">Poisons Standard October 2015 https://www.comlaw.gov.au/Details/F2015L01534</ref> A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.<ref name="Poisons Standard" />

===China===
As of October 2015 4-FMA is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

===United States===
As a close analog of [[Controlled Substances Act#Schedules of controlled substances|scheduled]] [[controlled substance]],<ref name=Rösner/> sale or [[Drug possession|possession]] of 4-FMA could be potentially be prosecuted under the [[Federal Analogue Act]].<ref>[https://www.erowid.org/psychoactives/law/analog/analog_info1.shtml Erowid Analog Law Vault : Federal Controlled Substance Analogue Act Summary]</ref>

== See also ==
{{colbegin|2}}
* [[2-Fluoromethamphetamine]] (2-FMA)
* [[3-Fluoromethamphetamine]] (3-FMA)
* [[3-Fluoroethamphetamine]] (3-FEA)
* [[4-Fluoroamphetamine]] (4-FA)
* [[4-Fluoromethcathinone]] (4-FMC)
* [[4-Methylmethamphetamine]] (4-MMA)
* [[4-Methoxymethamphetamine]] (PMMA)
* [[Fenisorex]]
{{colend}}

== References ==
{{Reflist|2}}

{{Entactogens}}
{{Stimulants}}
{{Monoamine releasing agents}}
{{Phenethylamines}}

{{DEFAULTSORT:Fluoromethamphetamine, 4-}}
[[Category:Designer drugs]]
[[Category:Methamphetamines]]
[[Category:Euphoriants]]
[[Category:Serotonin-norepinephrine-dopamine releasing agents]]
[[Category:Fluoroarenes]]
[[Category:Entactogens and empathogens]]